Overview

Oral Salt and Water to Prevent Contrast Nephropathy

Status:
Withdrawn
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot trial is to determine the safety and feasibility of using oral salt and water loading compared to intravenous saline for the prevention of contrast-induced acute kidney injury in patients with chronic kidney disease receiving a contrast-enhanced CT scan.
Phase:
Phase 4
Details
Lead Sponsor:
Ottawa Hospital Research Institute